Outcomes in Ethnic Minority Renal Transplant Recipients Receiving Everolimus versus Mycophenolate: Comparative Risk Assessment Results From a Pooled Analysis

BACKGROUND: Everolimus (EVR) has demonstrated good efficacy after renal transplantation. Racial disparities in clinical outcomes after de novo renal transplantation are well documented; whether the efficacy of EVR varies based on recipient ethnicity is unknown. We conducted a comparative risk assess...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Melancon, Keith, Mulgaonkar, Shamkant P., Delcoro, Carlos, Wiland, Anne, McCague, Kevin, Shihab, Fuad S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Lippincott Williams & Wilkins 2013
Θέματα:
Clinical and Translational Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888463/
https://ncbi.nlm.nih.gov/pubmed/24345868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e3182a486f5
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια